Progyny, Inc. - stock earnings

PGNY Quarterly earnings

DateEarningsRevenue
2023Q4 13.5 million USD 269.9 million USD
2023Q3 15.9 million USD 280.9 million USD
2023Q2 15.0 million USD 279.4 million USD
2023Q1 17.7 million USD 258.4 million USD
2022Q4 3.4 million USD 214.3 million USD
2022Q3 13.2 million USD 205.4 million USD
2022Q2 8.8 million USD 195.0 million USD
2022Q1 5.0 million USD 172.2 million USD
2021Q4 15.1 million USD 127.6 million USD
2021Q3 16.8 million USD 122.3 million USD
2021Q2 18.7 million USD 128.7 million USD
2021Q1 15.2 million USD 122.1 million USD
2020Q4 39.1 million USD 100.3 million USD
2020Q3 5.4 million USD 98.9 million USD
2020Q2 -1.8 million USD 64.6 million USD
2020Q1 4.1 million USD 81.0 million USD
2019Q4 -4.4 million USD 65.1 million USD
2019Q3 -8.2 million USD 61.2 million USD
2019Q2 1.5 million USD 56.2 million USD
2019Q1 2.5 million USD 47.2 million USD
2018Q4 -1.5 million USD 29.2 million USD
2018Q3 -1.1 million USD 27.8 million USD
2018Q2 -831000 USD 26.2 million USD
2018Q1 4.2 million USD 22.3 million USD

PGNY Yearly earnings

DateEarningsRevenue
2023 62.0 million USD 1.1 billion USD
2022 30.4 million USD 786.9 million USD
2021 65.8 million USD 500.6 million USD
2020 46.5 million USD 344.9 million USD
2019 -8.6 million USD 229.7 million USD
2018 661000 USD 105.4 million USD
2017 -12.5 million USD 48.6 million USD

PGNY

Price: $32.13

52 week price:
29.44
44.95

Earnings Per Share: 0.62 USD

P/E Ratio: 79.75

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Volume: 603200

Market Capitalization: 3.4 billion

Links: